You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
TATA健康(01255.HK)年度淨虧損收窄至6076.1萬港元 鞋類業務收入同比增長18.8%
格隆匯 04-01 01:15

格隆匯4月1日丨TATA健康(01255.HK)公佈,截至2021年12月31日止12個月,公司實現收益1.61億港元,同比增長3.58%;毛利1.05億港元,同比增長205.45%;公司擁有人應占虧損6076.1萬港元,去年同期虧損1.52億港元,基本及攤薄每股虧損0.26港元。

回顧2021年,新冠疫情仍然嚴峻,整體經濟仍不景氣,儘管如此,在堅持多元化戰略,即專注鞋類買賣,積極拓展保健產品,互聯網醫療及金融業務,年內集團業績仍獲得了可喜提升。

集團年度的鞋類業務收入約為1.53億港元,較2020年年度的約1.29億港元增加約18.8%。公司於年內的同店銷售錄得約23.6%的升幅。此乃主要由於本地客户消費情緒良好,且2021年第四季度的本地疫情轉為穩定,使銷售於該期內逐步復甦所致。

年度保健業務分部收入約為170萬港元,而本年度錄得的分部虧損約為490萬港元。收入較2020年年度減少乃由於澳洲持續爆發新冠肺炎及多月封城封關所致。儘管如此,保健業務分部仍在打造亞太地區知名的保健、護膚、母嬰護理及個人護理產品的跨境渠道供應鏈及分銷網絡。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account